FDA Device Center Gears Up For Product Reclassification Push
This article was originally published in The Gray Sheet
Executive Summary
FDA is hiring additional staff and channeling user fee funds toward device reclassification efforts now that it has committed itself to more rapidly addressing the subset of Class III devices that still enters the market via 510(k)
You may also be interested in...
Researchers Push FDA To Raise Standards For Metal-On-Metal Hips
Flaws in the 510(k) process prevented FDA from noticing high metal-on-metal revision rates, researchers write in the New England Journal of Medicine. Their argument is based on a predicate “ancestry” analysis of DePuy’s recalled ASR hip system.
Balloon Angioplasty Catheters Gain Quicker Path To Market Under FDA Rule
Standard balloon-tipped angioplasty catheters can enter the market through the 510(k) clearance process, rather than the PMA route, beginning next month
Balloon Angioplasty Catheters Gain Quicker Path To Market Under FDA Rule
Standard balloon-tipped angioplasty catheters can enter the market through the 510(k) clearance process, rather than the PMA route, beginning next month